Josep Tabernero

117PUBLICATIONS
863CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (117)

|Sep 29, 2026
Peripheral Blood as the Sole Source for Cancer Neoantigen and Reactive T-Cell Discovery.

|Sep 24, 2026
Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial.

|Sep 15, 2026
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial.

|Jul 13, 2026
Application of a Translational Research Platform to Unveil Efficacy Signals and Mechanisms of Resistance of FGFR Inhibitors in Multiple FGFR-Altered Solid Tumors.

|May 04, 2026
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

|Apr 21, 2026
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure.

Pageof 20

Frequent Collaborators

17 joint publications

Paulo Nuciforo

16 joint publications

Elena Elez

14 joint publications

Javier Ros

12 joint publications

Iosune Baraibar